Gastrointestinal

Five things for pharma marketers to know: Friday, September 16, 2016

Five things for pharma marketers to know: Friday, September 16, 2016

By

The FDA approves a combination of aspirin and heartburn medication; Teva partners with Intel to develop wearable; New Mexico AG sues BMS and Sanofi

How My GI Health changed the conversation for patients

How My GI Health changed the conversation for patients

By

The motivating force behind My GI Health met initial resistance. After all, it came from a company executive who professed that his goal was to benefit all companies within that therapeutic area.

Ironwood's McCourt bets big on data and the patient-physician dialogue

Ironwood's McCourt bets big on data and the patient-physician dialogue

By

Tom McCourt says he's "a marketing guy who hopefully understands a little about drug development" even as he guided drugs like Prilosec to market.

OPINION

Email Newsletters